Key insights
- FMC Corp's stock has significantly underperformed the S&P 500 over the past five years. High debt, patent expirations, and exploration of strategic options, including a potential sale, weigh on the stock. While recent revenue declines have moderated, and the company is focusing on cost-cutting and debt reduction, uncertainty remains. The stock is potentially undervalued based on forward P/E, but caution is advised.
Meet FMC Corp (FMC +2.36%) -- an agricultural sciences company that serves farmers by offering crop protection technologies to increase productivity. It's been around for more than 140 years, and has some strong core values, such as "We do things the right way. We are ethical, keep our commitments, and take responsibility for our actions." And "We create innovative solutions while preserving the environment for tomorrow."
How has the company's stock performed for investors? Well, not so terrifically. Those who invested, say, $10,000 five years ago would now be holding a stake worth around $2,000. Yikes!
That's an average annual loss of 27.6%, during a period when the S&P 500 averaged gains of 13.3%.
That's a terrible result, but a more important question for current shareholders and would-be shareholders alike is where the stock is likely to go from here. Arguably, those shares seem undervalued at recent levels, with a forward-looking price-to-earnings (P/E) ratio of 9.1, well below the five-year average of 12.4.
So what's the problem with FMC? Well, for one thing, it's carrying a lot of debt, in part due to acquisitions. It's also facing patent expirations for some key products. Worst of all, when the company reported its disappointing fourth-quarter results, management noted that it's exploring strategic options "including but not limited to the sale of the company."
Ugh, right? Well, on a more positive note, while revenue was down 12% year over year in the fourth quarter, the more recent first quarter of 2026 featured revenue down only 4%. The company is not necessarily doomed, though it has a lot of ground to regain. It's focusing on yield-boosting chemicals in a world where emerging markets will need to boost yields. It's selling its commercial India business to help pay down debt and is cutting costs.
It seems best to steer clear of FMC shares until its future is more clear and more rosy.